Latest Breaking News On - Our public health solutions - Page 13 : comparemela.com

Soligenix, and Graphex Group Interviews to Air on Bloomberg TV on the RedChip Money Report(R)

Soligenix, and Graphex Group Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesGraphex groupDevelopment authorityRedchip companiesBiomedical advanced researchGraphex group limitedUs developmentDefense threat reduction agencyNational institute of allergyRedchip companies incOur public health solutionsSoligenix incRedchip money reportInvestor relationsDiscovering tomorrowBlue chips

Soligenix, and Graphex Group Interviews to Air on Bloomberg TV on the RedChip Money Report(R)

Soligenix, and Graphex Group Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

United statesOur public health solutionsBiomedical advanced researchGraphex groupSoligenix incNational institute of allergyDevelopment authorityGraphex group limitedDefense threat reduction agencyUs developmentRedchip companies incRedchip companiesRedchip money reportInvestor relationsDiscovering tomorrowBlue chips today

Soligenix Announces European Patent Grant for Use of Dusquetide in Oral Mucositis

Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16, 2023 /PRNewswire/ Soligenix, Inc. , a late-stage biopharmaceutical. | May 16, 2023

United kingdomUnited statesNew zealandChristopherj schaberB brett finlayRobert hancockEuropean patent officeNational institute of allergyDefense threat reduction agencyUs congressUniversity of british columbiaDevelopment authorityPrnewswire soligenix incBiomedical advanced researchUs developmentRegulatory agency

Soligenix Announces Recent Accomplishments And First Quarter 2023 Financial Results

Soligenix Announces Recent Accomplishments And First Quarter 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSoligenix incUs congressBiomedical advanced researchDefense threat reduction agencyUs developmentExchange commissionDevelopment authorityPrnewswire soligenix incOur public health solutionsDrug administrationNational institute of allergyWhile the companyOffice of orphan products developmentChief executive officerSilk road therapeutics

Soligenix Announces Scheduling of Type A Meeting with the U S FDA to Review Proposed Study Design for a Second Phase 3 Study Evaluating HyBryte™ in the Treatment of Cutaneous T-Cell Lymphoma

/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing.

United statesChristopherj schaberUs congressUs developmentWhile the companyDrug administrationDevelopment authorityEuropean medicines agencyNational institute of allergyPrnewswire soligenix incSoligenix incDefense threat reduction agencyOur public health solutionsExchange commissionBiomedical advanced researchOutcome expected next